The Prostate Cancer Drug Development Summit is focused on clinical development of safe and effective treatments for prostate cancer.
The Prostate Cancer Drug Development Summit covers topics such as:
- Bringing theranostics to prostate cancer
- Role of immunotherapy for treatment of prostate cancer
- Assessing opportunities and challenges for T-cell directed therapies in prostate cancer
- Optimizing strategies for overcoming the immunosuppressive prostate tumor microenvironment
- Examining next-generation small molecule inhibitors, degraders of androgen receptor (AR) and AR-splice variants
The Prostate Cancer Drug Development Summit brings together:
- Oncologists
- Urologists
- Biotech
- Academics
- Pharma
